| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |